Join the Action Alerts PLUS Community today!
Drug maker AbCellera wins emergency use authorization for COVID treatment.
'Lilium won’t generate revenue for a few years. ... But Lilium could fundamentally reshape the transportation industry,' Piper said.
A 0.7% increase in retail sales for August was unable to push the market higher even though analysts had been expecting a decline.
'Many of the macro factors driving overearning by [Avis Budget] in 2021 will likely persist well into 2022,' Bank of America says.
Gap, American Express, Ford, DoorDash and Tuesday Morning are five top stock gainers for Thursday.
From supply chain shortages to big spending in Washington, Wall Street's historically toughest month has a number of additional factors at play this year.